Home »
NEW BRUNSWICK, N.J., September 23, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) […]
Read more
(HealthDay)—Compared with placebo, the addition of olaparib to maintenance therapy with bevacizumab is associated with a significant progression-free survival benefit for patients with advanced ovarian […]
Read more
(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according […]
Read more
As much as two fifths (43%) of antibiotic prescriptions in the United States could be inappropriate, warn researchers in a study published by The BMJ […]
Read more
A collaboration between Merck & Co and Codexis, Inc. has resulted in the development of a nine-enzyme, chain-reaction approach for making the HIV drug islatravir. […]
Read more
In a paper published in today’s online issue of the Journal of Alzheimer’s Disease, TauRx has reported unexpected results of a pharmacokinetic analysis of the […]
Read more
New findings from The University of Texas Medical Branch at Galveston show that patients qualifying for Medicare because of a disability have the highest rates […]
Read more
Experiencing a heart attack may be so terrifying that it triggers post-traumatic stress disorder (PTSD), and those who develop PTSD have twice the risk of […]
Read more
(HealthDay)—The June 2018 U.S. Food and Drug Administration label restriction on first-line immunotherapy for advanced bladder cancer was associated with a decrease in immunotherapy use […]
Read more
Inside a labor room at Brigham and Women’s Hospital in Boston, nurses and physicians monitored Yingzi Lin’s vitals, checking on her over the course of […]
Read more